Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Torri

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Acta Neurologica Scandinavica|December 6, 2017
Severe multiple sclerosis reactivation during prolonged lymphopenia after dimethyl fumarate discontinuationC Zecca, C G Antozzi, V Torri Clerici, et al.
International Journal of Breast Cancer|February 20, 2014
Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 StudyM E Cazzaniga, V Torri, F Villa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 5, 2011
Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'M Mandala, M Clerici, I Corradino, et al.
British Journal of Cancer|February 7, 2008
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysisR Fruscio, N Colombo, A A Lissoni, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
A proposal for a new approach to intergroup cancer trialsJ L Pater, B Zee, J Myles, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolitesM Ghielmini, E Colli, G Bosshard, et al.
European Heart Journal|February 1, 1994
Antihypertensive efficacy and tolerability of different drug regimens in isolated systolic hypertension in the elderlyF Avanzini, C Alli, G Bettelli, et al.
Cancer|June 4, 1998
GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma--long term results and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione Interventi in Oncologia. Studio Italiano Terapia Adiuvante ColonA Zaniboni, R Labianca, S Marsoni, et al.
American Journal of Public Health|January 1, 1991
The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancerA Liberati, G Apolone, A Nicolucci, et al.
British Journal of Cancer|January 1, 1997
Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cellsM Ghielmini, G Bosshard, L Capolongo, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Acta Neurologica Scandinavica|December 6, 2017
Severe multiple sclerosis reactivation during prolonged lymphopenia after dimethyl fumarate discontinuationC Zecca, C G Antozzi, V Torri Clerici, et al.
International Journal of Breast Cancer|February 20, 2014
Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 StudyM E Cazzaniga, V Torri, F Villa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 5, 2011
Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'M Mandala, M Clerici, I Corradino, et al.
British Journal of Cancer|February 7, 2008
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysisR Fruscio, N Colombo, A A Lissoni, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
A proposal for a new approach to intergroup cancer trialsJ L Pater, B Zee, J Myles, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolitesM Ghielmini, E Colli, G Bosshard, et al.
European Heart Journal|February 1, 1994
Antihypertensive efficacy and tolerability of different drug regimens in isolated systolic hypertension in the elderlyF Avanzini, C Alli, G Bettelli, et al.
Cancer|June 4, 1998
GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma--long term results and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione Interventi in Oncologia. Studio Italiano Terapia Adiuvante ColonA Zaniboni, R Labianca, S Marsoni, et al.
American Journal of Public Health|January 1, 1991
The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancerA Liberati, G Apolone, A Nicolucci, et al.
British Journal of Cancer|January 1, 1997
Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cellsM Ghielmini, G Bosshard, L Capolongo, et al.
Pageof 11